Zusammenfassung
Die Aufnahme eines Peptidhormons in die Zelle ist ein spezifischer Vorgang, der an die Präsenz des entsprechenden Rezeptors an der Zelloberfläche gebunden ist. Nach Erkennung und Komplexbildung werden die Hormonrezeptorkomplexe in Gruppen oder Clustern in Form eines endozytotischen Vesikels in die Zelle aufgenommen. Dieser Vorgang dient der Metabolisierung des Hormons, und bei einigen Hormonen, wie z.B. dem Prolaktin, auch der Metabolisierung des Rezeptors [101.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Blossey HC, Gaier B, Kohen F (1984) Properties of a prolactin-daunomycin (PRL-D) conjugate with intact hormone specificity. Proc. 7th Int Congr Endocrinology. Excerpta Medica, Amsterdam, p 423
Blossey HC, Gaier B, Zaltsman Y, Kohen F (1985) Prolactin-daunomycin conjugate inhibits in vitro growth and DNA synthesis in cells carrying the prolactin receptor. In: MacLeod RM, Thorner MO, Scapagnini U (eds) Prolactin. Basic and clinical correlates. Fidia Research Series vol I, Liviana Press, Padova, pp 367–373
Blossey HC, Gaier B, Zaltsman Y, Kohen F (to be published) Biologic activity and in vitro toxicity of a prolactin-daunomycin conjugate. Mol Cell Endocrinol
Bradford MM (1976) A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein dye binding. Analyt Biochem 72:248–254
Crooke ST, Duvernay VH, Mong S (1981) Molecular pharmacology of anthacyclines. In: Sartorelli AC, Lazo JS, Bertino JR (eds) Molecular actions and targets for cancer chemotherapeutic agents. Academic Press, New York London Toronto Sydney San Francisco, pp 137–162
Djiane J, Kelly PA, Houdebine LM (1980) Effects of lysosomotropic agents, cytochalasin B and colchicine on the „down-regulation“of prolactin receptors in mammary gland expiants. Molecular and Cellular Endocrinology 18:87–98
Josefsberg Z, Posner BI, Patel B, Bergeron JJM (1979) The uptake of prolactin into female rat liver. Concentration of intact hormone in the Golgi apparatus. The Journal of Biological Chemistry 254:209–214
Lindner HR, Kohen F, Amsterdam A (1980) An approach to site-directed chemotherapy of hormone-sensitive cancer. In: Iacobelli S, King RJB, Lippman ME, Lindner HR (eds): Hormones and cancer. Raven Press, New York, pp 541–550
Osborne CK, Hamilton B, Nover M (1982) Receptor binding and processing of epidermal growth factor by human breast cancer cells. J Clin Endocrinol Metab 55:86–94
Posner BI, Bergeron JJM, Josefsberg Z, Khan MN, Khan RJ, Patel BA, Sikstrom RA, Verma AK (1981) Polypeptide hormones: Intracellular receptors and internalization. Recent Progress in Hormone Research. 37:539–581
Rogol AD, Chrambach A (1975) Radioiodinated human pituitary and amniotic fluid prolactin with preserved molecular integrity. Endocrinology 97:406–417
Scatchard G (1949) The attraction of proteins for small molecules and ions. Annals of the New York Academy of Sciences 51:660–672
Tritton TR, Yee G (1982) The anticancer agent adriamycin can be actively cytotoxic without entering cells. Science 217:248–250
Turcot-Lemay L, Kelly PA (1982) Prolactin receptors in human breast tumors. J Natn Cancer Inst 68:381–383
Varga JM, Asato N, Lande S, Lerner AB (1977) Melanotropin-daunomycin conjugate shows receptor-mediated cytotoxicity in cultured murine melanoma cells. Nature 267:56–58
Wang C, Hsueh AJW, Erickson GF (1979) Induction of functional prolactin receptors by follicle-stimulating hormone in rat granulosa cells in vivo and in vitro. The Journal of Biological Chemistry 254:11330–11336
Wiesehahn G, Varga JM, Hearst JE (1981) Interactions of daunomycin and melanotropin-daunomycin with DNA. Nature 292:467–469
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1986 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Blossey, H.C., Gaier, B., Zaltsman, Y., Kohen, F. (1986). Biologische Erkennung eines Prolaktin-Daunomycin-Liganden in vitro und in vivo. In: Nagel, G.A. (eds) Mammakarzinome. Neue Perspektiven experimenteller und klinischer Therapieforschung. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-71041-4_16
Download citation
DOI: https://doi.org/10.1007/978-3-642-71041-4_16
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-71042-1
Online ISBN: 978-3-642-71041-4
eBook Packages: Springer Book Archive